About GEROPHARM
GEROPHARM is a company based in Saint Petersburg (Russia) founded in 2001. It operates as a Direct-to-Consumer (D2C) and Reseller / Distribution. GEROPHARM offers products and services including Insulin, Endocrinology Drugs, and Neurology Drugs.
- Headquarter Saint Petersburg, Russia
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website geropharm.com
- Social LinkedIn Facebook
- Legal Name Geropharm Jsc
- Investors
Products & Services of GEROPHARM
GEROPHARM offers a comprehensive portfolio of products and services, including Insulin, Endocrinology Drugs, and Neurology Drugs.
Insulin products are developed for diabetes treatment needs.
Drugs for endocrinology are produced to address hormonal issues.
Neurology drugs are manufactured to treat nervous system disorders.
Funding Insights of GEROPHARM
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of GEROPHARM with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2016 | – | Private Equity Round | – | – |
1 investors in total: 1 institutional.
Investors in GEROPHARM
GEROPHARM has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Russian Direct Investment Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sovereign wealth fund backed by Russian goverment and private equity firm focused on growth equities | – | rdif.ru | Moscow, Russia |
Investor details for GEROPHARM
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of GEROPHARM
2 dated milestones of GEROPHARM across 15 years, from founding to its latest funding, stage changes and deals.
- Founded GEROPHARM is founded.
- Funding First funding round.
Web traffic of GEROPHARM
The website of GEROPHARM (geropharm.com) receives about 6.8K visits a month and ranks #3,249,700 among all websites worldwide, #4,266 in Biotechnology and Pharmaceuticals.
- Monthly visits6.8K
▲ 24.7% vs previous month
- Unique visitors2.2K
per month
- Global rank#3,249,700
among all websites
- Category rank#4,266
Health · Biotechnology and Pharmaceuticals
- Bounce rate36%
- Pages per visit2.2
- Average visit2 min 05 sec
- DevicesDesktop 44% · Mobile 56%
Websites whose visitors overlap most with GEROPHARM. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| valentapharm.com | 100% | – | #819,765 | View details | |
| sentisspharma.com | 100% | 10.3K | #1,920,442 | View details | |
evalar.ru | evalar.ru | 60% | – | #31,311 | – |
longecity.org | longecity.org | 60% | – | #692,303 | – |
umedp.ru | umedp.ru | 59% | – | #171,239 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for GEROPHARM
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to GEROPHARM
10 companies that operate in the same segment as GEROPHARM (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GEROPHARM
GEROPHARM was founded in 2001 and raised its 1st funding round 15 years after it was founded.
GEROPHARM is headquartered in Saint Petersburg, Russia.
GEROPHARM is involved in the development and production of effective medicines, with a focus on biotechnology and insulin products. The company operates in sectors such as endocrinology, neurology, psychiatry, ophthalmology, and gynecology. Full-cycle drug development is conducted at its research center in Saint Petersburg. Manufacturing facilities are located in Pushkin and Obolensk, Russia, covering significant portions of the Russian insulin market needs. Solutions are aimed at creating a healthy future through technological innovation and industry advancements.
GEROPHARM offers Insulin, Endocrinology Drugs, and Neurology Drugs.
GEROPHARM has 1 investor. Key investors include Russian Direct Investment Fund.
GEROPHARM operates through Geropharm Jsc.